WallStSmart
SOPH

Sophia Genetics SA

NASDAQ: SOPH · HEALTHCARE · HEALTH INFORMATION SERVICES

$5.28
+5.60% today

Updated 2026-04-29

Market cap
$358.34M
P/E ratio
P/S ratio
4.64x
EPS (TTM)
$-1.17
Dividend yield
52W range
$3 – $6
Volume
0.1M

WallStSmart proprietary scores

26
out of 100
Grade: F
Strong Sell
Investment rating
6.7
Growth
B
4.5
Quality
C
2.0
Profitability
F
4.7
Valuation
C
2/9
Piotroski F-Score
Weak
-3.4
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$8.00
+51.52%
12-Month target
Intrinsic (DCF)
$4.63
Margin of safety
-3.24%
0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 22.40% QoQ
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -3.43 — distress zone
- Thin margins at -102.20%
- Negative free cash flow $-9.28M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$47.56M$62.37M$65.17M$77.27M$77.27M
Net income$-87.45M$-78.98M$-62.49M$-79.00M$-19.18M
EPS$-1.17
Free cash flow$-80.47M$-57.80M$-51.00M$-38.59M$-9.28M
Profit margin-183.87%-126.63%-95.89%-102.24%-102.20%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
SOPH$358.34M266.72.04.74.5-3.24%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Sophia Genetics SA trades at $5.28. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -3.43, it sits in the distress. TTM revenue stands at $77.27M. with profit margins at -102.20%. Our DCF model estimates intrinsic value at $4.63.

Frequently asked questions

What is Sophia Genetics SA's stock price?
Sophia Genetics SA (SOPH) trades at $5.28.
Is Sophia Genetics SA overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell). DCF value $4.63.
What is the price target of Sophia Genetics SA (SOPH)?
The analyst target price is $8.00, representing +51.5% upside from the current price of $5.28.
What is the intrinsic value of Sophia Genetics SA (SOPH)?
Based on our DCF model, intrinsic value is $4.63, a -3.2% margin of safety versus $5.28.
What is Sophia Genetics SA's revenue?
TTM revenue is $77.27M.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
-3.43 — distress.

Company info

SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio4.64x
ROE-110.00%
Beta1.05
50D MA$4.79
200D MA$4.37
Shares out0.07B
Float0.05B
Short ratio
Avg volume0.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years